Topical treatments (creams, gels, washes) work on the skin's surface — they're great for mild‑to‑moderate acne. Oral treatments (pills) work from the inside — they're for moderate‑to‑severe acne. The acne treatment market research shows that topicals hold 63% share, but orals are the fastest‑growing. Why? Because people are tired of spot‑treating and want systemic solutions.
What's in the oral pipeline? Sarecycline (a narrow‑spectrum antibiotic) with fewer side effects, and spironolactone for hormonal acne in women. The acne treatment market trends highlight that the female segment dominates (65% share), but the male segment is growing fast — men are finally seeking help for acne.
But oral treatments have risks: antibiotics can cause resistance; isotretinoin requires monthly blood tests and pregnancy prevention. That's why topicals remain first‑line.
The takeaway: start with topical. If that fails after 3 months, ask your dermatologist about oral options. Don't jump straight to Accutane — it's powerful, but it's not for everyone.
